Xilio Therapeutics, Inc.XLONASDAQ
Loading
Year-over-year net income growth rate
Percentile
P45
Within normal range
vs 3Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q3 2025 | -2.80% |
| Q2 2025 | -19.44% |
| Q1 2025 | -1.31% |
| Q4 2024 | 6.61% |
| Q3 2024 | -0.68% |
| Q2 2024 | 19.05% |
| Q1 2024 | 2.56% |
| Q4 2023 | -5.42% |
| Q3 2023 | 13.47% |
| Q2 2023 | 14.53% |
| Q1 2023 | -0.80% |
| Q4 2022 | -13.52% |
| Q3 2022 | 19.60% |
| Q2 2022 | -15.27% |
| Q1 2022 | -8.39% |
| Q4 2021 | -21.23% |
| Q3 2021 | 29.90% |
| Q2 2021 | -39.08% |
| Q1 2021 | 19.76% |
| Q4 2020 | -40.17% |
| Q3 2020 | -28.75% |
| Q2 2020 | -41.78% |
| Q1 2020 | 0.00% |